Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Cell Research - Tập 18 Số 10 - Trang 997-1006 - 2008
Xi Chen1, Yi Ba2, Lijia Ma3,4, Xing Fu Cai1, Yuan Yin1, Kehui Wang1, Jigang Guo1, Yujing Zhang1, Jiangning Chen1, Xing Guo1, Qibin Li3,4, Xiaoying Li5, Wenjing Wang6, Yan Zhang1, Jin Wang1, Xueyuan Jiang1, Yang Xiang1, Chen Xu1, Pingping Zheng3, Juanbin Zhang3, Ruiqiang Li3, Hongjie Zhang1, Xiaobin Shang7, Ting Gong7, Guang Ning5, Jun Wang3,4, Ke Zen1, Junfeng Zhang1, Chen-Yu Zhang1
1Nanjing University#TAB#
2Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Beijing Genomics Institute, Shenzhen, China
4Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
5Shanghai Jiao Tong Univ.
6Shanghai Municipal Center for Disease Control and Prevention
7Tianjin Medical University

Tóm tắt

Từ khóa


Tài liệu tham khảo

Duffy MJ . Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225–262.

Thomas CM, Sweep CG . Serum tumor markers: past, state of the art, and future. Int J Biol Markers 2001; 16:73–86.

Duffy MJ . Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med 2007; 18:175–184.

Roulston JE . Limitations of tumour markers in screening. Br J Surg 1990; 77:961–962.

Esquela-Kerscher A, Slack FJ . Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259–269.

Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857–866.

Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.

Tang F, Hajkova P, Barton SC, Lao K, Surani MA . MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.

Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3–12.

Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257–2261.

Leman ES, Schoen RE, Weissfeld JL, et al. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Res 2007; 67:5600–5605.

Ward DG, Suggett N, Cheng Y, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006; 94:1898–1905.

He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005; 102:19075–19080.

Garofalo M, Quintavalle C, Di Leva G, et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 2008; 27:3845–3855.

Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25:387–392.

El-Hefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004; 50:564–573.

Tsang JC, Lo YM . Circulating nucleic acids in plasma/serum. Pathology 2007; 39:197–207.

Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008; 54:482–490.

Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumor-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672–675.

Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513–10518.